SCHEMBL1829440

SCHEMBL1829440

Cc1cc2nc(CCC(=O)O)n(-c3ccccc3Cl)c(=O)c2c(C)c1C(=O)O

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ HDAC6 Q9UBN7 4/20 0.42
▸ PIK3CD O00329 1/20 0.41
▸ CNR1 P21554 1/20 0.41
▸ CNR2 P34972 1/20 0.41
▸ DHODH Q02127 2/20 0.40
▸ PDE10A Q9Y233 1/20 0.40
▸ KMT2A Q03164 1/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ CYP2D6 P10635 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ POLB P06746 1/20 0.38
▸ NOTUM Q6P988 1/20 0.38
▸ HPD P32754 1/20 0.38
▸ PIK3CG P48736 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1826000 0.90 CNR1 (0.52) HDAC6PIK3CDCNR1CNR2KMT2A
SCHEMBL1827713 0.82 CNR1 (0.52) PIK3CDCNR1CNR2KMT2AALDH1A1
SCHEMBL1824391 0.80 CNR1 (0.53) HDAC6PIK3CDCNR1CNR2KMT2A
SCHEMBL10973972 0.78 CNR1 (0.57) CNR1CNR2KMT2AALDH1A1KDM4E
SCHEMBL10975710 0.77 CNR1 (0.54) CNR1CNR2PDE10AKMT2AALDH1A1
SCHEMBL11075597 0.77 CNR1 (0.56) CNR1CNR2PDE10AKMT2AALDH1A1
SCHEMBL11071494 0.76 CNR1 (0.48) PIK3CDCNR1CNR2ALDH1A1KDM4E
SCHEMBL11081203 0.76 CNR1 (0.51) CNR1CNR2KMT2AALDH1A1LMNA
SCHEMBL11073415 0.75 CNR1 (0.48) PIK3CDCNR1CNR2ALDH1A1KDM4E
SCHEMBL11040498 0.74 CNR1 (0.51) CNR1CNR2KMT2AALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2319839-A1 Quinazolinone derivatives and their use as CB agonists Novartis AG (CH) 2011-05-11 — — EP disclosed
Send feedback